A strong infusion of cash could take Good Start Genetics (Cambridge, Massachusetts) to the next level in the development and marketing of its carrier screening applications. The firm spoke with Medical Device Daily on Tuesday about closing a non-dilutive loan facility for up to $28 million of capital from Capital Royalty.